Dendreon's test results won't speed drug approval

Seattle Times

Gonzalez, Angel

Newspaper

10/07/2008

C1-C2

Dendreon produced the drug, Provenge, for the treatment of advanced prostate cancer. Final tests on its efficacy were scheduled to start in mid-2009.

9237